Hypertension medication combined hyperlipidemic

High cholesterol hypertension patients heart, cerebrovascular accident important risk factors. Periodic inspection lipid levels, reduce hyperlipidemia, reduce coronary heart disease, stroke incidence and mortality is extremely important. However, some anti-hypertensive drugs on lipid metabolism have an adverse impact For example, diuretics (Thiazide diuretics and white) will increase the level of serum lipids; beta-blockers make blood triglyceride levels and increased high-density lipoprotein levels lowered. But recently, the clinic is used to be sympathetic endogenous activity of beta-blockers on lipid metabolism no obvious impact. Al-blocker and central sympathetic inhibitor of lipid metabolism, lower blood cholesterol levels. And angiotensin-converting enzyme inhibitors and calcium antagonists are not currently found on the lipid metabolism is negatively affected. Hypertension when combined hyperlipidemia preferred selective. Receptor blockers, calcium antagonists and angiotensin converting enzyme inhibitors, diuretics and beta on anti-receptor blockers, should also be strictly controlled calorie intake, reducing animal fat intake, when necessary with lipid-lowering drugs.